Pontis Biologics, Inc.
Research - Huntington, New York, United States
Pontis Biologics, Inc. Employees
Pontis Biologics, Inc. Senior Management
Pontis Biologics, Inc. Details
Pontis Biologics was founded in 2018. We set out to develop an at home oral hygiene product worthy of the 21st century. Pontis' focus was a model based on the constituents of the oral environment: oral microbiome, saliva components and oral epithelial products. These facts, combined with fundamental principles of biochemistry and biophysics, were used to formulate a new model of tartar formation. Pontis has data demonstrating that the formulation is completely safe, affordable and effective at eliminating, not just reducing, tartar/calculus. The formulation (Tartarase) can enter the marketplace as a cosmetic with FDA oversight limited to assessing safety. Founder Dennis Mynarcik has a pending composition of matter patent in the US and internationally, wholly owned by Pontis. We have excellent pre-clinical data and are preparing for human clinical trials with a company recognized and respected by the American Dental Association. Pontis is seeking to establish a partnership with an established healthcare/pharma company to formulate, market, and distribute the dentifrice worldwide.
Pontis Biologics, Inc. Technologies
Fonts
Google Font API
Hosting
Amazon AWS
Other
Mobile Friendly